Core Viewpoint - Royal Philips has announced the expanded commercial availability of LumiGuide 3D Device Guidance, the first real-time AI-enabled light-based 3D navigation solution for image-guided therapy, across Europe and the United States, marking a significant advancement in radiation-free navigation technology [2][10]. Group 1: Product Overview - LumiGuide allows physicians to visualize and guide devices inside the body using light instead of continuous X-ray, enhancing radiation safety and dose reduction in image-guided therapy [2][5]. - The technology integrates seamlessly with Philips' Azurion platform, which is designed to drive procedural innovation across various clinical domains [3][9]. - LumiGuide utilizes Fiber Optic RealShape (FORS) technology to provide high-resolution, full-color images in real-time, enabling precise navigation during complex endovascular procedures [5][8]. Group 2: Clinical Impact - Clinical experiences indicate that LumiGuide can improve efficiency, reduce procedure time, and minimize fluoroscopy pedal usage, with complex aortic repair procedures performed 37% faster and with up to 56% reduction in dose area product (DAP) [4][5]. - Over 2,000 clinical procedures have utilized LumiGuide, demonstrating its effectiveness and integration with the Azurion platform [10]. Group 3: Market Expansion - Following a successful limited market release in late 2023, LumiGuide will be commercially available from January 2026 in key European markets and the United States, expanding access to advanced image-guided therapy [10][14]. - Philips aims to enhance the adoption of this technology in hospitals to improve treatment precision and safety while reducing radiation risks for both patients and clinical staff [6][7]. Group 4: Commitment to Safety - LumiGuide is part of Philips' broader portfolio aimed at reducing or eliminating radiation exposure during image-guided procedures, reinforcing the company's leadership in low- and no-dose interventional solutions [11][14]. - The integration of LumiGuide with other technologies like Azurion with ClarityIQ and DoseAware further emphasizes Philips' commitment to advancing radiation safety in medical procedures [11].